Research Focus: Bispecific Antibodies in Multiple Tumor Types

Get up to date on the latest data on the use of currently approved and investigational bispecific antibodies in managing hematologic malignancies and solid tumors with this expert-authored text module and accompanying downloadable slides.
Anthony Stein, MD

Module

In this concise text module, receive expert guidance on the use of currently approved bispecific antibody therapy and review data on emerging bispecific antibodies under investigation for treating numerous cancer types.

Anthony Stein, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: April 27, 2020 Expired: April 26, 2021
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Amgen

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?